• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2 APPLICATION; FLASH GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2 APPLICATION; FLASH GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 71857-01
Device Problem Application Program Problem (2880)
Patient Problems Hypoglycemia (1912); Loss of consciousness (2418)
Event Date 07/31/2023
Event Type  Injury  
Event Description
A customer reported that the adc application was incompatible with their samsung galaxy a13 phone.As a result, the customer reported they were unable to obtain glucose readings and experienced a loss of consciousness.The customer was administered an unspecified iv and what they believe to be glucagon.No further details were provided.There was no report of death or permanent impairment associated with this event.
 
Manufacturer Narrative
The customer¿s product data has been requested for investigation.A follow-up report will be filed once additional information is obtained.The exact date of event is unknown.The date entered in section b3 is per the customer's report of "july." the device manufacturing date does not apply.The date entered in section h4 is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
 
Manufacturer Narrative
An extended investigation has been performed for the reported complaint and it has been determined that there were no issues with the freestyle libre 2 application that would have led to the complaint.The customer called in reporting incompatibility device issue when using the freestyle libre 2 application.Smartphone compatibility with the use of freestyle libre 2 app device has not been tested at the time of the investigation.The compatibility guide states that abbott diabetes care has not assessed compatibility on phone/operating systems other than those listed.Successfully scanned and received glucose readings and alarm notification using similar device configuration.Therefore, this complaint is not confirmed.All pertinent information available to abbott diabetes care has been submitted.
 
Event Description
A customer reported that the adc application was incompatible with their samsung galaxy a13 phone, app version 2.As a result, the customer reported they were unable to obtain glucose readings and experienced a loss of consciousness.The customer was administered an unspecified iv and what they believe to be glucagon.No further details were provided.There was no report of death or permanent impairment associated with this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 2 APPLICATION
Type of Device
FLASH GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
1360 south loop road
alameda CA 94502 7001
Manufacturer Contact
audra fuentes
1360 south loop road
alameda, CA 94502-7001
5107495297
MDR Report Key17834644
MDR Text Key324484339
Report Number2954323-2023-42960
Device Sequence Number1
Product Code QLG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K193371
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 10/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number71857-01
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/30/2023
Initial Date FDA Received09/28/2023
Supplement Dates Manufacturer Received10/02/2023
Supplement Dates FDA Received10/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/30/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-